Androgen Abuse in Athletes: Detection and Consequences

Department of Medicine, Division of Endocrinology and Metabolism, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
The Journal of Clinical Endocrinology and Metabolism (Impact Factor: 6.31). 02/2010; 95(4):1533-43. DOI: 10.1210/jc.2009-1579
Source: PubMed

ABSTRACT Doping with anabolic androgenic steroids (AAS) both in sports (especially power sports) and among specific subsets of the population is rampant. With increasing availability of designer androgens, significant efforts are needed by antidoping authorities to develop sensitive methods to detect their use.
The PubMed and Google Scholar search engines were used to identify publications addressing various forms of doping, methods employed in their detection, and adverse effects associated with their use.
The list of drugs prohibited by the World Anti-Doping Agency (WADA) has grown in the last decade. The newer entries into this list include gonadotropins, estrogen antagonists, aromatase inhibitors, androgen precursors, and selective androgen receptor modulators. The use of mass spectrometry has revolutionized the detection of various compounds; however, challenges remain in identifying newer designer androgens because their chemical signature is unknown. Development of high throughput bioassays may be an answer to this problem. It appears that the use of AAS continues to be associated with premature mortality (especially cardiovascular) in addition to suppressed spermatogenesis, gynecomastia, and virilization.
The attention that androgen abuse has received lately should be used as an opportunity to educate both athletes and the general population regarding their adverse effects. The development of sensitive detection techniques may help discourage (at least to some extent) the abuse of these compounds. Investigations are needed to identify ways to hasten the recovery of the gonadal axis in AAS users and to determine the mechanism of cardiac damage by these compounds.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study is to review four case-based scenarios regarding the treatment of symptomatic hypogonadism in men. The article is designed as a review of published literature. We conducted a PubMed literature search for the time period of 1989-2014, concentrating on 26 studies investigating the efficacy of various therapeutic options on semen analysis, pregnancy outcomes, time to recovery of spermatogenesis, as well as serum and intratesticular testosterone levels. Our results demonstrated that exogenous testosterone suppresses intratesticular testosterone production, which is an absolute prerequisite for normal spermatogenesis. Cessation of exogenous testosterone should be recommended for men desiring to maintain their fertility. Therapies that protect the testis involve human chorionic gonadotropin (hCG) therapy or selective estrogen receptor modulators (SERMs), but may also include low dose hCG with exogenous testosterone. Off-label use of SERMs, such as clomiphene citrate, are effective for maintaining testosterone production long-term and offer the convenience of representing a safe, oral therapy. At present, routine use of aromatase inhibitors is not recommended based on a lack of long-term data. We concluded that exogenous testosterone supplementation decreases sperm production. It was determined that clomiphene citrate is a safe and effective therapy for men who desire to maintain fertility. Although less frequently used in the general population, hCG therapy with or without testosterone supplementation represents an alternative treatment.
    05/2015; 4(2):245-53. DOI:10.5527/wjn.v4.i2.245
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this work, the electrochemical investigation of testosterone, a steroid hormone from the androgen group, was carried out in aqueous and aqueous/surfactant solutions using a glassy carbon (GC) electrode. In cyclic voltammetry, the compound showed one irreversible and adsorption-controlled reduction peak. Addition of cationic surfactant (cetyltrimethylammonium bromide, CTAB) was found to enhance the reduction current signal of testosterone, whereas, anionic (sodium dodecylsulfate, SDS) and non-ionic (Tween 80) surfactants exhibited opposite effect. Using square-wave adsorptive stripping voltammetry, the current showed a linear dependence with concentration in the range between 10 and 70 nM in Britton-Robinson buffer, pH 5.0 containing 3 mM CTAB. A detection limit of 1.18 nM (0.34 ng mL(-1)), and relative standard deviation of 4.12% for a concentration level of 35 nM (n = 11) were calculated. This method was successfully applied for the analysis of testosterone in oil-based pharmaceutical preparations and urine samples without any separation.
    Electrochimica Acta 05/2014; 128:54-60. DOI:10.1016/j.electacta.2013.10.024 · 4.09 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The abuse of Anabolic Androgenic Steroids (AAS) has become a widespread use among professional and recreational athletes. They are used to improve their physical performance and body image. This article intends to review the Anabolic Androgenic Steroids (AAS) abuse and its clinical management in order to serve as a tool to aid in diagnosis of this potentially serious form of drug abuse. Studies published in Pubmed between 2000‐2013 were included in the review and also from The Journal of Family Practice, American Family Physician, Medicina Desportiva Informa and sites of Autoridade Antidopagem de Portugal and Diário da República. It is important that health professionals be aware, not only for the possible indicators of abuse and its negative health effects, but also its social context. There are other performance‐enhancing drugs that health professionals need to recognize its deleterious health effects.
    11/2014; DOI:10.1016/j.rpedm.2014.09.002